InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Discover the detailed record of transactions filed by Kimball Aaron, Officier. Officer active across 1 company, notably Zymergen Inc.. Aggregated, 12 disclosures have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €829k. History available since 6 October 2021. The latest transaction was disclosed on 1 April 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
25,000 shares@ US$2.84297.1% of flowCommon StockSEC:0001645842-22-000052:0
25,000 shares@ US$3.81389.5% of flowCommon StockSEC:0001645842-22-000028:0
25,000 shares@ US$5.064212.5% of flowCommon StockSEC:0001645842-22-000013:0
25,000 shares@ US$5.064230.1% of flowCommon StockSEC:0001645842-22-000013
50,000 shares@ US$5.181660.6% of flowCommon StockSEC:0001645842-22-000007
50,000 shares@ US$5.181625.3% of flowCommon StockSEC:0001645842-22-000007:0
5,000 shares0Common StockSEC:0001645842-21-000042
5,000 shares0Common StockSEC:0001645842-21-000042:0
85,000 shares0Common StockSEC:0001645842-21-000025
85,000 shares0Common StockSEC:0001645842-21-000025:0
9,000 shares@ US$4.473.9% of flowCommon StockSEC:0001645842-21-000020:0
9,000 shares@ US$4.479.3% of flowCommon StockSEC:0001645842-21-000020
12 of 12 declarations
About Kimball Aaron
Aaron Kimball is the Chief Technology Officer of Zymergen Inc. In this role, he oversees the company's technology operations. Zymergen is a biotechnology company specializing in innovation. Aaron plays a key role in developing new technologies and innovation.
